Stay updated on Imvotamab in Non-Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Imvotamab in Non-Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Imvotamab in Non-Hodgkin Lymphoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedEnrollment status shows the study is no longer enrolling, and new help sections were added to assist users. The Intervention heading was standardized to Intervention/Treatment and the revision tag updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check19 days agoChange DetectedThe revision label on the page was updated from v3.5.4 to v3.5.5, indicating a newer site build. No study details or visible functionality appear to be affected by this change.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page now shows revision v3.5.4 instead of v3.5.3, indicating a small site update to the interface or backend.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page indicates an update of its site/portal release version from v3.5.0 to v3.5.3, reflecting a backend or tooling revision rather than any new or modified study information.SummaryDifference0.0%

- Check98 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No user-facing study details or layout changes are evident.SummaryDifference0.0%

- Check112 days agoChange DetectedRevision tag updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Imvotamab in Non-Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imvotamab in Non-Hodgkin Lymphoma Clinical Trial page.